Your browser doesn't support javascript.
loading
Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer.
Rabinowicz, Noa; Mangala, Lingegowda S; Brown, Kevin R; Checa-Rodriguez, Cintia; Castiel, Asher; Moskovich, Oren; Zarfati, Giulia; Trakhtenbrot, Luba; Levy-Barda, Adva; Jiang, Dahai; Rodriguez-Aguayo, Cristian; Pradeep, Sunila; van Praag, Yael; Lopez-Berestein, Gabriel; David, Ahuvit; Novikov, Ilya; Huertas, Pablo; Rottapel, Robert; Sood, Anil K; Izraeli, Shai.
Affiliation
  • Rabinowicz N; Cancer Research Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Mangala LS; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Brown KR; Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
  • Checa-Rodriguez C; Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas, USA.
  • Castiel A; Donnelly Centre and The Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario, Canada.
  • Moskovich O; Department of Genetics, University of Sevilla and Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER), Sevilla, Spain.
  • Zarfati G; Cancer Research Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Trakhtenbrot L; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Levy-Barda A; Cancer Research Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Jiang D; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Rodriguez-Aguayo C; Cancer Research Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Pradeep S; Cancer Research Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • van Praag Y; Cancer Research Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Lopez-Berestein G; Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
  • David A; Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas, USA.
  • Novikov I; Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas, USA.
  • Huertas P; Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, Texas, USA.
  • Rottapel R; Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
  • Sood AK; Cancer Research Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Izraeli S; Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas, USA.
Oncotarget ; 8(16): 27380-27392, 2017 Apr 18.
Article in En | MEDLINE | ID: mdl-28423708
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA Damage / Intracellular Signaling Peptides and Proteins / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: Israel Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA Damage / Intracellular Signaling Peptides and Proteins / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: Israel Country of publication: United States